Revive Therapeutics deal

Revive Therapeutics Inc. reverse-merged with shell company Mercury Capital II Ltd. to form Revive Therapeutics Ltd., which began trading under the symbol "RVV" on the TSX Venture. The newco issued 16.6 million shares to Revive Therapeutics Inc. shareholders, which represents a 70% stake. The company said it valued the shares at C$0.30, which is the price of Mercury Capital II's July 2013 IPO. The price values the 70% stake at C$5 million ($4.7 million). ...